Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Humana ( (HUM) ) has shared an announcement.
Humana Inc. reported a net loss for Q4 2024, with a GAAP net loss per share of $5.76 and an adjusted net loss per share of $2.16, but the company affirmed its guidance for 2025, expecting adjusted earnings per share to be at least in line with 2024 results. Despite a decline in individual Medicare Advantage membership due to exiting unprofitable plans, Humana continues to advance its Medicaid and CenterWell strategies, expected to enhance earnings in the long term.
More about Humana
Humana Inc. operates in the healthcare industry, primarily offering health insurance products and services, with a strong focus on Medicare Advantage, Medicaid, and other health plan services.
YTD Price Performance: 5.60%
Average Trading Volume: 1,665,840
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $33.03B
See more insights into HUM stock on TipRanks’ Stock Analysis page.
